Microwave Ablation Market (2026 - 2033)

Microwave Ablation Market Summary

The microwave ablation market size was valued at USD 494.9 million in 2025 and is projected to grow from USD 569.8 million in 2026 to USD 1,302.0 million by 2033, at a CAGR of 12.5% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 31.2% in 2025. The market growth can be attributed to the increasing incidence of various cancers, including liver, lung, kidney, and bone cancers.

According to the American Cancer Society, in 2024, the U.S. projected approximately 2,001,140 new cancer cases, with notable figures of 234,580 for lung cancer, 41,630 for liver cancer, and 81,610 for kidney cancer. These statistics underscore the rising demand for effective treatment options, particularly those such as microwave ablation that offer minimally invasive solutions targeting tumors with precision and safety.

Advancements in medical technology serve as another catalyst for market growth. Continuous improvements in microwave ablation devices have enhanced their effectiveness through innovations such as real-time imaging guidance and artificial intelligence integration. Such technological developments are becoming essential as the cancer treatment landscape evolves, resulting in improved treatment outcomes and reduced complications for patients diagnosed with increasingly prevalent cancers. This trend aligns with the growing focus on employing advanced methodologies to address the rising number of cancer diagnoses effectively.

In 2024, around 65% of patients undergoing cancer treatment expressed a preference for minimally invasive techniques, which typically provide shorter recovery times and decreased postoperative pain compared to traditional surgical methods. This notable demand for innovative treatment modalities, such as microwave ablation, highlights the changing attitudes toward surgical interventions in the oncology field, making them more appealing to both patients and providers.

This trend is especially pronounced in North America and Europe, where collaborative efforts between healthcare institutions, research organizations, and medical device manufacturers are fostering innovation. Such partnerships enhance access to microwave ablation technologies and drive market growth, as they enable the development of new solutions tailored to meet the rising demands of cancer treatment amid an evolving healthcare landscape.

Market Dynamics

The microwave ablation market is positioned at the intersection of several long-term oncology, interventional radiology, and minimally invasive surgical care trends, including the rising global burden of cancer, increasing prevalence of chronic liver and lung diseases, and continuous advancements in image-guided thermal ablation technologies. Microwave ablation solutions enable hospitals, cancer centers, ambulatory surgical centers, and interventional radiology clinics to treat a broad range of malignant and benign tumors through precise, localized thermal destruction of diseased tissue. These technologies are widely utilized in the management of liver cancer, lung cancer, kidney tumors, bone metastases, and other soft-tissue lesions, providing minimally invasive treatment alternatives for patients who may not be suitable candidates for conventional surgery. Modern microwave ablation systems utilize advanced microwave generators, high-performance ablation antennas, real-time temperature monitoring technologies, and sophisticated imaging guidance platforms to deliver controlled and predictable tissue coagulation. Integration with ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and fusion imaging technologies enables precise lesion targeting, enhanced procedural accuracy, and improved treatment planning. These innovations support complete tumor coverage while minimizing damage to surrounding healthy tissues, thereby improving clinical outcomes and reducing procedure-related complications.

Analyst Perspective

The global microwave ablation market is positioned at the intersection of several long-term oncology, minimally invasive intervention, and precision medicine trends, including the rising global incidence of cancer, increasing preference for image-guided minimally invasive therapies, and continuous advancements in thermal ablation technologies. The growing prevalence of primary and metastatic tumors involving the liver, lung, kidney, bone, and other soft tissues is creating significant growth opportunities for medical device manufacturers, interventional radiology providers, and cancer treatment centers. This expansion is accelerating as healthcare systems, oncologists, and interventional specialists increasingly seek effective treatment alternatives that can deliver precise tumor destruction, reduced procedural complications, shorter hospital stays, and faster patient recovery compared with conventional open surgical approaches. Microwave ablation has emerged as an attractive therapeutic option for patients who are poor surgical candidates or require repeat local tumor control, further supporting its clinical adoption across a broad range of oncological applications. 

Component Type Insights

Based on component type, the accessories segment led the market with the largest revenue share of 51.3% in 2025. The accessories segment predominantly comprises applicator antennas, which effectively deliver energy to tissue and offer numerous advantages and clinical applications. Typically, multiple antennas are utilized in a single procedure to create extensive and reproducible ablation zones. Key attributes of these antennas include minimal invasiveness and high efficiency in penetrating deep tissues for optimal active heating. However, anatomical structures such as airways, blood vessels, bile ducts, and the bowel can impact antenna performance. Leading companies, such as Medtronic, are advancing this market with innovative products such as the Emprint SX navigation antenna and Emprint Percutaneous Antennas featuring Thermosphere Technology.

Generators are expected to grow at the fastest CAGR of 14.4% over the forecast period. Generators play a crucial role in delivering power to multiple antennae, adhering to stringent safety standards in human medicine due to close proximity to patients. Features include integrated DC/DC protection, real-time temperature and RF power monitoring, and durable connectors for extended service life. Notable advancements include AMICA Microwave and RF System Gen by Mermaid Medical, a programmable, combined RFA and MWA technology.

Application Insights

Based on application, the oncology segment led the market with the largest revenue share of 31.3% in 2025, driven by rising cancer incidence, particularly among liver, lung, kidney, and bone cancer patients, creating a need for effective treatment options. Factors contributing to the demand include the minimally invasive nature of microwave ablation, technological advancements, and increased awareness and acceptance among healthcare professionals and patients.

Cardiovascular applications are expected to register the fastest CAGR of 14.3% over the forecast period. Microwave ablation has become a safe and effective treatment for atrial fibrillation (AF), particularly in patients with concurrent cardiac conditions, with significant success in achieving stable sinus rhythm. Its minimally invasive nature allows for procedures on a beating heart, which reduces recovery times. Continuous technological advancements enhance efficacy and safety, driving demand as the prevalence of cardiovascular diseases rises.

End-use Insights

Based on end use, the hospital segment led the market with the largest revenue share of 46.3% in 2025 as they serve as primary healthcare providers for patients requiring microwave ablation, particularly for cancer treatment, due to their comprehensive services that enhance access to advanced care. Equipped with state-of-the-art technology and specialized expertise, hospitals efficiently perform complex procedures. According to the American Hospital Association, insurance reimbursement supports affordability, while the extensive network of over 6,200 hospitals in the U.S. underscores their capacity for delivering these services.

Research laboratories are projected to grow at the fastest CAGR of 14.3% over the forecast period. Research laboratories drive innovation in microwave ablation technologies and techniques, enhancing their efficacy and safety. They conduct clinical trials to validate effectiveness, particularly for cancer treatment, which bolsters acceptance in clinical practice. Collaborations with medical institutions further enhance credibility, while educational initiatives inform healthcare professionals about microwave ablation's benefits. In 2023, approximately 1.3 million researchers globally contribute to these advancements.

Regional Insights

North America dominated the microwave ablation market with the largest revenue share of 31.2% in 2025. It is projected that the region would continue to grow as a result of technological advancements and the rising prevalence of chronic diseases. There is a strong demand for imaging analysis due to the rising prevalence of chronic diseases in this area, such as cardiovascular disorders. For instance, the CDC estimates that about 805,000 Americans get a heart attack each year. Over the projected period, the region is anticipated to continue to dominate.

U.S. Microwave Ablation Market Trends

The microwave ablation market in the U.S. held the largest share in the North America region in 2025. Market growth in the country is driven by substantial investments in healthcare technology and research. The presence of leading medical device manufacturers encourages innovation, while the high incidence of cancer cases escalates demand for effective treatment options. Favorable insurance coverage and reimbursement policies incentivize hospitals to implement microwave ablation procedures.

Europe Microwave Ablation Market Trends

Europe microwave ablation market held substantial market share in 2024. Increasing cancer incidence rates and heightened awareness of minimally invasive procedures are driving industry growth in the country. Elevated healthcare expenditures across European countries promote the adoption of advanced medical technologies. Furthermore, regulatory approvals for microwave ablation devices and growing collaborations between healthcare providers and manufacturers enhance market growth in this region.

The microwave ablation market in UK is expected to grow in the forecast period, influenced by a growing aging population, with approximately 18% aged 65 and older as of 2023. The rising incidence of cancers, such as liver and lung cancer, necessitates effective treatment options such as microwave ablation. Moreover, advancements in medical technology and supportive healthcare policies facilitate the adoption of these innovative therapies in clinical practice.

Asia Pacific Microwave Ablation Market Trends

Asia Pacific microwave ablation market is expected to register the fastest CAGR of 14.5% in the forecast period, driven by increased healthcare investments and a rising prevalence of chronic diseases, including cancer. Countries such as China and India are experiencing notable growth due to expanded healthcare infrastructure and enhanced access to advanced medical technologies. Moreover, a larger patient population seeking efficient treatment options fuels demand for microwave ablation procedures.

Japan microwave ablation market dominated the Asia Pacific microwave ablation market in 2024, supported by an aging population, with approximately 28% of citizens aged 65 and older as of 2023. The high prevalence of cancers, particularly liver and lung cancers, drives the demand for effective treatment options such as microwave ablation. Japan's advanced healthcare system further facilitates the adoption of innovative medical technologies, improving patient access to these therapies.

Key Microwave Ablation Company Insights

Some key companies operating in the market include AngioDynamics; Medtronic; Emblation Ltd.; HUBER+SUHNER; Johnson & Johnson Services, Inc.; among others. The market is fragmented owing to high competition at the global level as it has the presence of severe key players. These players focus on growth strategies, such as new product launches, collaborations, partnerships, operational expansion, mergers & acquisitions, and patient awareness campaigns.

• AngioDynamics specializes in microwave ablation systems designed for soft tissue treatment, particularly the Solero MTA System. This system utilizes a solid-state generator to achieve effective spherical ablations of up to 5 cm in just 6 minutes.

• HUBER+SUHNER supplies essential connectivity components for microwave ablation devices, including low-loss cables and connectors. Their solutions enhance energy transfer efficiency and ensure compliance with medical safety standards, supporting both miniaturization and reliability in ablation technology.

Key Microwave Ablation Companies

The following key companies have been profiled for this study on the microwave ablation market.

• AngioDynamics

• Medtronic

• Emblation Ltd.

• HUBER+SUHNER

• Johnson & Johnson Services, Inc.

• MedWaves, Inc.

• SympleSurgical Inc.

• Mermaid Medical

• Varian Medical Systems, Inc.

• Terumo Corporation

Competitive Benchmarking

Recent Developments

• In December 2024, AngioDynamics received FDA clearance for the NanoKnife System, enabling prostate tissue ablation and enhancing treatment options.

• In November 2024, Johnson & Johnson MedTech received FDA approval for the VARIPULSE Platform in the U.S. for treating atrial fibrillation.

• In October 2024, Medtronic received FDA approval for the Affera Mapping and Ablation System with Sphere-9 Catheter in the U.S., enhancing treatment options for persistent atrial fibrillation.

• In July 2024, Varian received FDA 510(k) clearance for its IntelliBlate microwave ablation system in the U.S., providing clinicians with enhanced predictability, precision, and control during procedures.

• In February 2024, Biosense Webster obtained CE mark approval for the VARIPULSE Platform in Europe, enabling real-time integrated 3D mapping for treating recurrent paroxysmal atrial fibrillation through pulsed field ablation.

Microwave Ablation Market Report Scope

Global Microwave Ablation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global microwave ablation market report based on component type, application, end-use, and region:

• Component Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Generator

  • Power Distribution System

  • Accessories

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Oncology

  • Cardiovascular

  • Urology

  • Orthopedic

  • Others

• End-use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospital

  • Ambulatory Surgery Centers

  • Research Laboratories

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The microwave ablation market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each microwave ablation segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Estimation Model

Delivered Customizations

This report has been delivered with the following In-depth customizations